CD82 Antibody - C-terminal region : FITC (ARP63361_P050-FITC)

This metastasis suppressor gene product is a membrane glycoprotein that is a member of the transmembrane 4 superfamily. Expression of this gene has been shown to be downregulated in tumor progression of human cancers and can be activated by p53 through a consensus binding sequence in the promoter. Its expression and that of p53 are strongly correlated, and the loss of expression of these two proteins is associated with poor survival for prostate cancer patients. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.

GGT1; CD81; CD53; UBC; LGALS3BP; AMFR; VANGL1; IGSF8; ITGA3; NUP88; PTGFRN; ITGB2; ITGA4; ERBB3; CD4; ERBB2; CD63; ITGA6; HLA-DRA; HLA-DMB; HLA-DMA; ITGB1; EGFR; HBEGF; CANX; LRP1; CD19; ITGAL; HLA-DOB; CD46; CD151; CD9; RUVBL1; POLR2A; KAT5; CTNNB1; RUVB

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.